<DOC>
	<DOCNO>NCT02077036</DOCNO>
	<brief_summary>The overall aim study investigate effect new , non-pharmacological method may alleviate symptom narcolepsy thereby lead reduction use medication potentially serious side effect patient disease .</brief_summary>
	<brief_title>Narcolepsy - New Potential Treatment</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<criteria>Signed informed consent Diagnosed narcolepsy ( diagnose code G47.4 ) 16 60 year age MSLT show hypersomnia ( sleep latency &lt; 8 min ) &amp; 1 episode REM HLAtype associate increased occurrence narcolepsy Reduced cognitive function Other relevant organ disease ( could affect study result put patient risk ) Ongoing bacterial infection nose Comorbidity increase risk bleeding Has receive treatment implantable stimulator implantable product head / neck Known pronounce septal deviation Known allergy polyvinylchloride medicinal liquid paraffin Women use adequate contraceptive Participated clinical investigational drug trial within previous 30 day</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>